Search results
Marshall biomedical engineering professor receives award
The Daily Independent, Ashland, Ky. via Yahoo News· 6 days agoNational Science Foundation's CAREER Award in the amount $604,047. The funds will be granted over the next five years and go toward her research project, "Exploring the Differentiation of < ...
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing...
Nature· 6 days agoCancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical outcomes. Damage to ...
Further CYP-001 GvHD Clinical Data Published in Nature Medicine
The Woonsocket Call· 4 days agoCynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce the publication of two-year ...
StemCyte Renews Contract with the California State Umbilical Cord Blood Collection Program
CBS 47 Fresno· 3 days agoStemCyte, a leader in cord blood-based regenerative therapeutics in Southern California, is excited to announce the renewal of its partnership with the California State Umbilical Cord Blood ...
Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)
Insider Monkey via Yahoo Finance· 5 days agoEuropean stocks started the day on May 21 with a slightly weaker note, marking a retreat from their...
Logiq, Inc. Signs Letter of Intent to Acquire Privately Held Biotech Company MedLab Essentials, LLC...
Digital Journal· 3 days agoPRESS RELEASE Published May 23, 2024 ACCESSWIRE NEW YORK, NY / ACCESSWIRE / May 23, 2024 / Logiq, Inc. (OTC Markets:LGIQ) ("Logiq" or "the Company"), a pioneering force in digital consumer acquisition ...
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 1 day agoStockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology ...
Using hybrid nanotubes to enhance cancer treatment with intracellular protein delivery
Phys.org· 6 days agoThe intracellular delivery of proteins is an important technique for unveiling the cellular...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoMELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it received a notice
